C-Type Lectins and Immune Surveillance in ALD
C-Type Lectins and Immune Surveillance in ALD
批准号:
10426861
负责人:
Adam Kim
金额:
$6.16万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
已结题
起止时间:
2021-09-01 至 2022-08-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary
This Administrative Supplement will provide an additional year of mentored research to compensate for
research progress and career development that was delayed due to the COVID-19 pandemic. The pandemic
forced research labs at the Cleveland Clinic to reduce to a quarter or half capacity for the last year, reduced the
number of patients enrolled in studies, and decreased access to many critical lab supplies including reagents.
As a result, research focus had to be shifted to remote work, and many year 1 and year 2 research and career
goals for the K99 were unmet. During this extra year, the candidate will be able to finish experiments that were
put off due to the pandemic and continue to develop skills in clinical immunology, generate the sequencing data
outlined in the proposal, and learn leadership skills to transition into independence.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
C-Type Lectins and Immune Surveillance in ALD
-
批准号:10925432
-
项目类别:
-
资助金额:$16.6万
-
财政年份:2022
-
负责人:Adam Kim
-
依托单位:
C-Type Lectins and Immune Surveillance in ALD
-
批准号:10683563
-
项目类别:
-
资助金额:$24.88万
-
财政年份:2022
-
负责人:Adam Kim
-
依托单位:
C-Type Lectins and Immune Surveillance in ALD
-
批准号:10020883
-
项目类别:
-
资助金额:$12.31万
-
财政年份:2019
-
负责人:Adam Kim
-
依托单位:
海外基金